Andre Choulika is the founder of Cellectis. Latest round: IPO. Based in Paris, France.
André Choulika is the co-founder, Chairman, and CEO of Cellectis, a gene-editing company he founded in 1999. He has played a key role in the company's growth, including raising over €3 billion in financing in 2014 and achieving a Nasdaq listing in 2015. He was born in Beirut and is recognized as a significant figure in gene-editing.
Full founder directory · Investor directory · Company funding database · Fundraising library